SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Microcide Pharmaceuticals (MCDE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John O'Neill who wrote (149)2/10/1998 1:33:00 PM
From: Larry G.  Read Replies (1) of 186
 
John et all, who are looking at the 22 Billion US target market of antibiotics. Have any compared MCDE to that which I have been invested in for a while. It is a Canadian stock call Micrologix Biotech. MBI-TSE It cost $3.50 Canadian or $2.50 US. Their has been a lot of developments and the price has not risen. I'm not saying to sell MCDE but it may be a good idea to diversify.

One of their enhancins has restored the ability Vancomycin to act against Vacomycin resistant bacteria.

Message 1559814

They have a lot of developments in a number of areas. If any one could compare, I would appreciate it.

You can get information about company by calling 1-800-665-1968

Larry G
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext